← Leaderboards
Phil Holland Alday
Portland Va Medical Center
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2020–24$1$1$1$0$0
'20
'21
'22
'23
'24
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Portland Va Medical Center
Same institution · by research overlap
- Michael Kevin Riscoe$14,982,665
- Joseph Stone Doggett$229,542
Others in their field
Other Emerging Leaders on “Acute Infection”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$50,268,550
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Scott Fry$21,470,000
- Gina Montealegre · Leidos Biomedical Research, Inc.$19,781,641
- Greg Witham · Anp Technologies, Inc.$19,727,817
Research focus
Acute InfectionAntibioticsAnti-Infective AgentsApplications GrantsBiochemicalBiochemistryBiologyBlindnessBrainBrain DiseasesCareer DevelopmentCaringCellsCessation Of LifeChemotherapyChronic InfectionClinicCommunicable DiseasesConsultCrispr/Cas TechnologyCystDisabilityDiversity LibraryAbsorption
Grant awards (5)
Development of new drugs for Toxoplasma by advancing hits from the Global Health Chemical Diversity Library$0
IK2 · FY2024 · VA · contact PI
Development of new drugs for Toxoplasma by advancing hits from the Global Health Chemical Diversity Library$0
IK2 · FY2023 · VA · contact PI
Development of new drugs for Toxoplasma by advancing hits from the Global Health Chemical Diversity Library$0
IK2 · FY2022 · VA · contact PI
Development of new drugs for Toxoplasma by advancing hits from the Global Health Chemical Diversity Library$0
IK2 · FY2021 · VA · contact PI
Development of new drugs for Toxoplasma by advancing hits from the Global Health Chemical Diversity Library$0
IK2 · FY2020 · VA · contact PI